Related Experiment Video

Updated: Jan 2, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

793

Combined Rifampin and Sulbactam Therapy for Multidrug-Resistant Acinetobacter Baumannii Ventilator-Associated

Jinlan Chen1,2, Yifeng Yang1, Kun Xiang1

  • 1Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.

Journal of Anesthesia and Perioperative Medicine
|December 11, 2019
PubMed

Insights

A combination of rifampicin and sulbactam sodium shows promise for treating extensively drug-resistant Acinetobacter baumannii (XDR-Ab) pneumonia in critically ill children. This treatment led to successful recovery in most pediatric patients, with manageable side effects.

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Resistance
  • Critical Care Medicine

Background:

  • Extensively drug-resistant Acinetobacter baumannii (XDR-Ab) poses a significant threat to pediatric patients, particularly those with ventilator-associated pneumonia (VAP).
  • Limited therapeutic options exist for treating XDR-Ab infections in infants and young children, highlighting an urgent need for effective treatments.

Purpose of the Study:

  • To evaluate the clinical outcomes of pediatric patients with XDR-Ab VAP treated with a combination of rifampicin and sulbactam sodium.
  • To assess the safety and efficacy of this combination therapy in a vulnerable pediatric population.

Main Methods:

  • A retrospective study involving 12 critically ill infants and young children with XDR-Ab VAP post-congenital heart surgery.
  • Data collected included clinical outcomes, microbiological responses, and adverse events.
  • The study received institutional review board (IRB) approval.

Main Results:

  • Ten out of twelve patients (83%) were successfully weaned from mechanical ventilation and discharged.
  • Two patients expired due to complex underlying conditions.
  • Adverse effects, including rash and elevated aminotransferase levels, were observed in three patients.

Conclusions:

  • Rifampicin combined with sulbactam sodium appears to be an effective and safe therapeutic option for severe XDR-Ab VAP in pediatric patients.
  • Adverse effects were generally reversible upon timely discontinuation of rifampicin.
Abstract

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.1K
In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging09:29

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging

Published on: April 28, 2017

9.8K

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
500
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
392
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
702
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
243
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
177
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
472